| Ms كارين كاتن
| -- |
| Mr جان إيف جيل
| -- |
| Mr دومينيك رينيش
| -- |
| Ms بيتسي اتكينس
| -- |
| Mr دينيس دوفيرن
| -- |
| Mr هنري دى كاستريس
| -- |
| Mr Philippe Luscan
| Philippe Luscan is a graduate of the École Polytechnique and the École des Mines in Biotechnology in Paris. He began his career in 1987 as a Production Manager at Danone. In 1990, he joined the Group as Director of the Sanofi Chimie plant at Sisteron, France, and subsequently served as Industrial Director of Sanofi in the United States, as Vice President Supply Chain and as Vice President Chemistry in September 2006. He was appointed to his present position in September 2008. |
| Mr Christopher Viehbacher
| Christopher Viehbacher, Chief Executive Officer and Director. Other current directorships and appointments - Chairman of the Executive Committee and the Management Committee of sanofi-aventis, Member of the Strategy Committee of sanofi-aventis, Chairman of the Board of Directors of PhRMA (United States), Vice Chairman of EFPIA (Belgium), Member of the Board of Directors of Research America (United States) and Burroughs Wellcome Fund (United States), Member of the Board of Visitors of Fuqua School of Business, Duke University (United States), Member of the Board of Business Roundtable (United States). Education and business experience - Graduate in Commerce of Queens University (Ontario-Canada); certified public accountant, Began his career at PricewaterhouseCoopers Audit. 1998-2008 - Various positions at the GSK group, including President Pharmaceutical Operations for North America. Past directorships held since 2006 - Director of GlaxoSmithkline plc until November 2008 (United Kingdom), Member of the Board of Triangle United Way (United States, 2003-2008), of Cardinal Club (United States, 2004-2008) and GlaxoSmithKline NC Foundation (United States, 2003-2008), Vice Chairman of Portfolio Management Board of GSK plc (United Kingdom, 2007-2008), Member of Advisory Council of Center for Healthcare Transformation (United States, until 2010). Date of Birth - March 26, 1960, Nationalities - German and Canadian. Christopher Viehbacher is a citizen of Germany and Canada. |
| Mr Roberto Pucci
| Roberto Pucci has a law degree from the University of Lausanne, Switzerland. He started his career in 1985 at Coopers & Lybrand in Geneva, Switzerland as an external auditor. He then joined Hewlett-Packard (HP) in 1987, where he held various positions in Human Resources in Switzerland and Italy including HR Manager for the European Headquarters and Human Resources Director in Italy. In 1999, he became Director, Compensation & Benefits for Agilent Technologies, a spin off from HP, and was appointed Vice President Human Resources Europe in 2003. In 2005 he moved to the United States to join Case New Holland, a subsidiary of the Fiat Group, as Senior Vice President, Human Resources, and was appointed, in 2007, Executive Vice President, Human Resources for the Fiat Group in Torino, Italy. Roberto Pucci joined Sanofi as Senior Vice President Human Resources in October 2009. Roberto Pucci is a citizen of Italy and Switzerland. |
| Mr Jerome Contamine
| Jérôme Contamine is a Graduate of École Polytechnique (X), ENSAE, and ENA (Ecole Nationale d'Administration). After four years at the Cour des Comptes, as a Senior State General Auditor, he joined Elf Aquitaine in 1988, as advisor to the Chief Financial Officer, and became Group Finance and Treasury Director in 1991. He became the General Manager of Elf Petroleum Norway in 1995, after being named Deputy Vice President of Elf Upstream Division for Europe and the U.S. In 1999, he was appointed as a member of the taskforce for integration with Total, in charge of the reorganization of the merged entity, TotalFinaElf, and in 2000 became Vice President Europe and Central Asia, Upstream Division of Total. The same year, he joined Veolia Environnement as CFO and Deputy General Manager. In 2003, he was appointed Vice-President Senior Executive, Deputy Chief Executive Officer, Financial Director of Veolia Environnement. Jérôme Contamine joined Sanofi as Executive Vice President, Chief Financial Officer (CFO) of Sanofi in March 2009. |
| Mr سيرج اينبرغ
| -- |
| Mr Lindsay Owen-Jones
| Lindsay Owen-Jones, Director. Other current directorships and appointments - Member of the Compensation Committee, of the Appointments and Governance Committee and of the Strategy Committee of sanofi-aventis, Chairman of the Board of Directors of L’Oréal, Chairman of the Strategy and Implementation Committee of L’Oréal, Chairman of the Board of Directors of Fondation d’Entreprise L’Oréal (Foundation), Chairman of Alba Plus, L’Oréal UK Ltd (United Kingdom) and L’Oréal USA Inc. (United States), Director of Ferrari S.p.A. (Italy), Education and business experience - Bachelor of Arts (Hons) from Oxford University and degree from INSEAD, Since 1969 - Various positions at the L’Oréal group, including Chairman and Chief Executive Officer (1988-2006) and Chairman of the Board of Directors since April 25, 2006, 1989-2005 - Director of BNP Paribas. Past directorships held since 2006 - Chief Executive of L’Oréal (1988-2006), Vice-President and member of the Supervisory Board of L’Air Liquide (2001-2006), Vice-Chairman of the Board of Directors of L’Air Liquide (2006-2009), Director of Galderma Pharma until 2006. Date of Birth - March 17, 1946. Nationality - British. |
| Mr كلاوس بوهلي
| -- |
| Mr روبرت سارتجن
| -- |
| Mr جيرارد فان كيميل
| -- |
| Mr كريستيان ماييز
| -- |
| Mr Olivier Charmeil
| Olivier Charmeil is a graduate of HEC (Ecole des Hautes Etudes Commerciales) and of the Institut d'Etudes Politiques in Paris. From 1989 to 1994, he worked in the Mergers & Acquisitions department of Banque de l'Union Européenne. He joined Sanofi Pharma in 1994 as head of Business Development. Subsequently, he held various posts within the Group, including Chief Financial Officer (Asia) for Sanofi-Synthélabo in 1999 and Attaché to the Chairman, Jean-François Dehecq, in 2000, before being appointed as Vice President, Development within the Sanofi-Synthélabo International Operations Directorate, where he was responsible for China and support functions. In 2003, Olivier Charmeil was appointed Chairman and Chief Executive Officer of Sanofi-Synthélabo France, before taking the post of Senior Vice President, Business Management and Support within the Pharmaceutical Operations Directorate. In this role, he piloted the operational integration of Sanofi-Synthélabo and Aventis. He was appointed Senior Vice President Asia/Pacific, Pharmaceutical Operations in February 2006 and since January 1, 2008, Operations Japan have reported to him as well as Asia/Pacific and Japan Vaccines since February 2009. Since January 1, 2011, Olivier Charmeil has served as Senior Vice President Vaccines and a member of the Executive Committee. |
| Mr هيلي كريستوفرسين
| -- |
| Mr تشارلز- هنرى فليبى
| -- |
| Mr دانيال جولوت
| -- |
